Successful treatment of severe hypertriglyceridemia with plasmapheresis - Case report;Plazmafereza jako skuteczna metoda leczenia cieżkiej hipertriglicerydemii - Opis przypadku

Polski Merkuriusz Lekarski

Volumn 26, Issue 151, 2009, Pages 62-64

  Hen, Katarzyna ^a,b   Bogdański, Paweł ^a,b,c   Pupek Musialik, Danuta ^a,b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Department of Internal Medicine Metabolic Disorders and Hypertension ^*  (Poland)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Acute pancreatitis; Hypertriglyceridemia; Plasmapheresis

Indexed keywords

ACUTE DISEASE; ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; PANCREATITIS; PLASMAPHERESIS;

ACUTE DISEASE; ADULT; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; PANCREATITIS; PLASMAPHERESIS;

EID: 59849084855     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Baggio G., Manzato E., Gabelli C. i wsp.: Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients. J. Clin. Invest., 1986, 77, 520-527.
2. Bambauer R., Schiel R., Latza R.: Low-density lipoprotein apheresis: an overview. Ther. Apher. Dial., 2003, 7, 4, 382-390.
3. Bambauer R., Schiel R., Latza R.: Low density lipoprotein apheresis in treatment of hyperlipidemia: experience with four different technologies. The Apher, 2000, 4, 3, 213-217.
4. Capell W.H., Eckel R.H.: Severe hypertriglyceridemia with a history of treatment failure. Nat. Clin. Pract. Endocrinol. Metabol., 2005, 1, 1, 53-58.
5. Gan S.I., Edwards A.L., Symonds C.J. i wsp.: Hypertriglyceridemia- induced pancreatitis: A case-based review, World J. Gastroenterol., 2006, 12, 44, 7197-7202.
6. Giannini G., Valbonesi M., Morelli F. i wsp.: Hypertriglyceridemia: apheretic treatment, Int. J. Artif. Organs, 2005, 28, 10, 1018-1021.
7. Henzen C., Rock M., Schnieper C. i wsp.: Heparin and insulin the treatment of acute hypertriglyceridemia-induced pancreatitis, Schweiz. Med. Wochenschr, 1999, 129, 1242-1248.
8. Ito H., Naito C., Hayashi H. i wsp.: Selective removal of triglyceride-rich lipoproteins by plasmapheresis in diabetic patients with severe hypertriglyceridemia. Artif. Organs, 1989, 13, 3, 190-196.
9. Kyriakidis A.V., Raitsiou B., Sakagianni A. i wsp.: Management of acute severe hyperlipidemic pancreatitis. Digestion, 2006, 73, 4, 259-264.
10. Morelli F., Carlier P., Giannini G. i wsp.: Hypercholesterolemia and LDL apheresis. Int. J. Artif. Organs, 2005, 28, 10, 1025-1031.
11. Nierman M.C., Rip J., Twisk J. i wsp.: Gene therapy for genetic lipoprotein lipase deficiency: from promise to practice. Neth. J. Med., 2005, 63, 1, 14-19.
12. Parhofer K.G., Geiss H.C., Schwandt P., Efficacy of different low-density lipoprotein apheresis methods. Ther. Apher., 2000, 4, 5, 382-385.
13. Pejic R.N., Lee D.T.: Hypertriglyceridemia. J. Am. Board Fam. Med., 2006, 19, 310-316.
14. Piolot A., Nadler F., Cavallero E. i wsp.: Prevention of recurrent acute pancreatitis In patients with severe hypertriglyceridemia: value of regular plasmapheresis. Pancreas, 1996, 13, 1, 96-99.
15. Sattler A.M., Bock K., Schmidt S. i wsp.: LDL-Apheresis for the treatment of hyperchylomicronemia-induced pancreatitis. Z. Kardiol., 2003, 92, 3, III64-67.
16. Schmidt H.H.-J., Genschel J., Baier P. i wsp.: Dyslipidemia in familial partial lipodystrophy caused by an R482W mutation in the LMNA gene. J. Clin. Endocrynol. Metabol., 2001, 86, 5, 2289-2295.
17. Sleth J.C., Lafforgue E., Servais R. i wsp.: A case of hypertriglyceridemia-induced pancreatitis in pregnancy: value of heparin. Ann. Fr. Anesth. Reanim., 2004, 23, 8, 835-837.
18. Vantyghem M.C., Pigny P., Maurage C.A. i wsp.: Patients with Familial Partial Lipodystrophy of the Dunnigan Type Due to a LMNA R482W Mutation Show Muscular and Cardiac Abnormalities. J. Clin. Endocrynol. Metabol., 2004, 89, 11, 5337-5346.
19. Wykrywanie, ocena i leczenie hipercholesterolemii u doroslych - cz. IV, III Raport Zespołu Ekspertów National Cholesterol Education Program (USA) skrót. Medycyna Praktyczna, 2003, 6, 148, 65-81.